March 2026
M	T	W	T	F	S	S
	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Robert Talac: Platelet Concentration Gap – PRP vs Advanced PRF

Robert Talac/LinkedIn

Mar 27, 2026, 16:26

Robert Talac: Platelet Concentration Gap – PRP vs Advanced PRF

Robert Talac, Medical Director at Renaxis Regenerative Orthopedic Center, shared a post on LinkedIn:

“PRP Has More Platelets. Except When It Doesn’t.

I’ve made two arguments in my last 2 posts:

1. Standard PRP contains foreign substances. PRF – in plain glass tubes – doesn’t.
2. PRP’s growth-factor burst is the wrong delivery profile for durable regeneration.

Here’s the counterargument I hear most often:
‘Fine. But PRP still delivers higher platelet concentration.’

Let’s look at the numbers.

Standard PRP across most commercial systems:
3-8x whole blood concentration.

Buffy-coat PRP systems tend to be on the higher end.
Some reach slightly above 8x.

Now PRF:

A-PRF (solid fibrin): 17.9x whole blood
CGF (solid PRF derivative): 15.5x
C-PRF (liquid): 12-17x – with some preparations exceeding 20x

Miron et al. quantified C-PRF from the buffy-coat fraction and reported increases of 1,200-1,700% over whole blood.
Concentrations routinely above 2,000-3,000 x 10⁹/L.

At those levels, we’re no longer talking about a marginal difference from PRP.
We’re looking at a fundamentally different concentration range.

To be precise: these are advanced PRF formulations – A-PRF, CGF, C-PRF – not standard low-speed PRF. Technique and protocol matter. But that’s exactly the point.

The field has moved.

Advanced PRF preparations have closed – and in most cases, reversed – the platelet concentration gap that once gave PRP its primary quantitative advantage.

The argument for PRP on concentration grounds was never rock-solid.
Against modern PRF protocols, it doesn’t hold at all.

Three arguments for PRP orthodoxy. Three answers from the evidence.”

Robert Talac